Medical Condition: RSV Vaccine
Facility/Clinic: Accellacare (1907 Tradd Court)
Age: > 60 Years of Age
Description: Phase 3 study to assess the efficacy, safety, and reactogenicity of RSV vaccine in patients 60 years of age and older; Qualifying patients will receive 1 dose of RSV vaccine, complete an electronic symptom diary 3 times per week, and participate in monthly follow-up phone calls for 1 year. On-site sick visits will occur throughout the year if patient reports presence of respiratory symptoms.
Enrollment: April 2022 – August 2022
Patient Commitment Duration: ~ 12 months
Number of visits in study: 2 onsite visits + symptom/sick visits, monthly phone calls for 12 months
Patient Compensation: TBD
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.